Literature DB >> 15782990

Prognostic implications of preserved bile duct confluence after iatrogenic injury.

Miguel Angel Mercado1, Carlos Chan, Héctor Orozco, Carlos A Hinojosa, Eitan Podgaetz, Guillermo Ramos-Gallardo, Raul Gálvez-Treviño, Magdalena Valdés-Villarreal.   

Abstract

BACKGROUND/AIMS: Biliary reconstruction is performed according to the level of the injury. A comparative study between patients in whom the biliary junction was preserved and another group where the biliary junction was not preserved was done.
METHODOLOGY: A retrospective review of the biliary reconstructions performed at our institution after iatrogenic lesions between 1990-2002 was done. Postoperative outcome, functional status of the anastomosis, recurrent cholangitis, need for radiological instrumentation and/or reoperation were analyzed.
RESULTS: We reviewed 204 cases, 130 cases had a preserved biliary junction while in 74 the injury included the junction. All patients were treated with a Roux-en-Y hepatojejunostomy. In the first group, 4% required reoperation, 4% underwent radiological percutaneous instrumentation, 8% had anastomotic dysfunction and 4% cholangitis. In the second group, 24% needed reoperation and 80% radiological instrumentation. Anastomotic dysfunction was observed in 64% and cholangitis in 55%. It is important to note that 52 of the 74 cases in the second group had a history of more than two reconstruction attempts.
CONCLUSIONS: When the biliary junction is preserved after a iatrogenic injury we found a significantly better outcome. The results of biliary reconstruction in this type of patient are better long-term compared to those where the junction was not preserved, evidenced by a lower reoperation and radiological instrumentation rate.

Entities:  

Mesh:

Year:  2005        PMID: 15782990

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Early versus late repair of bile duct injuries.

Authors:  Miguel Angel Mercado
Journal:  Surg Endosc       Date:  2006-10-23       Impact factor: 4.584

2.  Acute Cholangitis After Bilioenteric Anastomosis for Bile Duct Injuries.

Authors:  Edgar Ortiz-Brizuela; José Sifuentes-Osornio; Daniel Manzur-Sandoval; Santiago Mier Y Terán-Ellis; Sergio Ponce-de-León; Pedro Torres-González; Miguel Ángel Mercado
Journal:  J Gastrointest Surg       Date:  2017-07-25       Impact factor: 3.452

3.  Surgical management and outcome of bile duct injuries following cholecystectomy: a single-center experience.

Authors:  Jerzy Lubikowski; Mariola Post; Andrzej Białek; Janusz Kordowski; Piotr Milkiewicz; Maciej Wójcicki
Journal:  Langenbecks Arch Surg       Date:  2011-02-19       Impact factor: 3.445

4.  Outcome assessment of biliary stricture repair following cholecystectomy in a tertiary care centre.

Authors:  Ravi Shankar Biswas; Nihar Ranjan Dash; Anand Narayan Singh; Rajesh Panwar; Sujoy Pal; Peush Sahni
Journal:  Langenbecks Arch Surg       Date:  2022-09-22       Impact factor: 2.895

5.  An analysis of early postoperative complications following biliary reconstruction of major bile duct injuries using the Modified Accordion and Anatomic, Timing Of and Mechanism classifications.

Authors:  Jessica Lindemann; Eduard Jonas; Urda Kotze; Jake Ej Krige
Journal:  Surg Open Sci       Date:  2019-03-03

6.  Laparoscopic bile duct injuries: timing of surgical repair does not influence success rate. A multivariate analysis of factors influencing surgical outcomes.

Authors:  Lygia Stewart; Lawrence W Way
Journal:  HPB (Oxford)       Date:  2009-09       Impact factor: 3.647

7.  Iatrogenic bile duct injury with loss of confluence.

Authors:  Miguel-Angel Mercado; Mario Vilatoba; Alan Contreras; Pilar Leal-Leyte; Eduardo Cervantes-Alvarez; Juan-Carlos Arriola; Bruno-Adonai Gonzalez
Journal:  World J Gastrointest Surg       Date:  2015-10-27

8.  Intrahepatic repair of bile duct injuries. A comparative study.

Authors:  Miguel Angel Mercado; Carlos Chan; Noel Salgado-Nesme; Federico López-Rosales
Journal:  J Gastrointest Surg       Date:  2007-11-29       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.